Efficacy and safety of mitiglinide versus nateglinide in newly diagnose patients with type 2 diabetes mellitus: a randomized double blind trial

Double Blind Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Blind Trial

Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance

The Lancet ◽

10.1016/s0140-6736(09)60222-1 ◽

2009 ◽

Vol 373 (9675) ◽

pp. 1607-1614 ◽

Cited By ~ 190

Author(s):

Ryuzo Kawamori ◽

Naoko Tajima ◽

Yasuhiko Iwamoto ◽

Atsunori Kashiwagi ◽

Kazuaki Shimamoto ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Glucose Tolerance ◽

Impaired Glucose Tolerance ◽

Double Blind Trial ◽

Double Blind ◽

Blind Trial

A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes Mellitus

Case Medical Research ◽

10.31525/ct1-nct03962010 ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Phase 2 ◽

Efficacy And Safety ◽

Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study

Diabetologia ◽

10.1007/s00125-021-05460-0 ◽

2021 ◽

Author(s):

Linong Ji ◽

Ying Du ◽

Min Xu ◽

Xiangjun Zhou ◽

Zhaohui Mo ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Phase Ii ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Treatment Naïve

Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone

Current Medical Research and Opinion ◽

10.1185/03007995.2014.909393 ◽

2014 ◽

Vol 30 (7) ◽

pp. 1257-1266 ◽

Cited By ~ 44

Author(s):

Anil Pareek ◽

Nitin Chandurkar ◽

Nihal Thomas ◽

Vijay Viswanathan ◽

Alaka Deshpande ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Efficacy And Safety ◽

Re: Pareek A, Chandurkar N, Thomas N, et al. Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone. Curr Med Res Opin 2014;30:1257-66

Current Medical Research and Opinion ◽

10.1185/03007995.2015.1035242 ◽

2015 ◽

Vol 31 (6) ◽

pp. 1087-1092

Author(s):

Anil Pareek

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Efficacy And Safety ◽

Efficacy and safety of exenatide as add‐on therapy for patients with type 2 diabetes with an intensive insulin regimen: A randomized double‐blind trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.14225 ◽

2020 ◽

Author(s):

Michael Joubert ◽

Victoria Opigez ◽

Barbora Pavlikova ◽

Laure Peyro Saint Paul ◽

Nathalie Jeandidier ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Regimen ◽

Double Blind Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Blind Trial

Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus

Cardiovascular Diabetology ◽

10.1186/s12933-016-0407-4 ◽

2016 ◽

Vol 15 (1) ◽

Cited By ~ 35

Author(s):

Nobuya Inagaki ◽

Shin-ichi Harashima ◽

Nobuko Maruyama ◽

Yutaka Kawaguchi ◽

Maki Goda ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Japanese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Efficacy and safety of alogliptin in patients with type 2 diabetes mellitus: A multicentre randomized double-blind placebo-controlled Phase 3 study in mainland China, Taiwan, and Hong Kong

Journal of Diabetes ◽

10.1111/1753-0407.12425 ◽

2016 ◽

Vol 9 (4) ◽

pp. 386-395 ◽

Cited By ~ 10

Author(s):

Changyu Pan ◽

Ping Han ◽

Qiuhe Ji ◽

Chengjiang Li ◽

Juming Lu ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Hong Kong ◽

Mainland China ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12047 ◽

2013 ◽

Vol 15 (5) ◽

pp. 432-440 ◽

Cited By ~ 90

Author(s):

K. Kaku ◽

S. Inoue ◽

O. Matsuoka ◽

A. Kiyosue ◽

H. Azuma ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Glycaemic Control ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetes

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2017.10.018 ◽

2018 ◽

Vol 138 ◽

pp. 253-261 ◽

Cited By ~ 8

Author(s):

Philip Home ◽

R. Ravi Shankar ◽

Ira Gantz ◽

Carol Iredale ◽

Edward A. O'Neill ◽

...

Keyword(s):

Type 2 Diabetes ◽

Dipeptidyl Peptidase ◽

Double Blind Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Dipeptidyl Peptidase 4 ◽

Blind Trial ◽

Dipeptidyl Peptidase 4 Inhibitor